2019
DOI: 10.1016/j.bmcl.2019.04.005
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis, and biological evaluation of novel 2′-deoxy-2′-fluoro-2′-C-methyl 8-azanebularine derivatives as potent anti-HBV agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 35 publications
0
2
0
Order By: Relevance
“…To build a pyrimidine ring based on 5-amino-4-triazolocarboxylic acid amides 83 and to form 3,6-disubstituted triazolo [4,5-d] orthoesters [8,34,47,48], amides and formic acid esters were used as one-carbon reagents [41, 49 -51], as well as Vilsmeier-Haack reagent [50] (Scheme 25).…”
Section: The Cyclization Of 5-amino-123-triazole-4-carboxamidesmentioning
confidence: 99%
“…To build a pyrimidine ring based on 5-amino-4-triazolocarboxylic acid amides 83 and to form 3,6-disubstituted triazolo [4,5-d] orthoesters [8,34,47,48], amides and formic acid esters were used as one-carbon reagents [41, 49 -51], as well as Vilsmeier-Haack reagent [50] (Scheme 25).…”
Section: The Cyclization Of 5-amino-123-triazole-4-carboxamidesmentioning
confidence: 99%
“…HBV therapy with nucleoside analogs, in long term, has developed resistance and obvious decreased inhibition effects [ 8 , 9 , 10 ]. The disadvantages of nucleoside analogs prompted us and other researchers to invent and find new structural non-nucleoside analog compounds [ 11 , 12 , 13 , 14 , 15 , 16 ]. Many anti-HBV bioactive non-nucleoside analog compounds have been designed and developed on the basis of their interactions with receptor using molecular docking [ 17 , 18 , 19 , 20 , 21 ].…”
Section: Introductionmentioning
confidence: 99%